Alpha Tau Medical Ltd

DRTS
2,405
0,005 (0,21%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/3/202413:50GLOBEAlpha Tau to Present at the Jefferies Radiopharma Innovation..
07/3/202422:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202422:01GLOBEAlpha Tau Medical Announces Full Year 2023 Financial Results..
26/2/202414:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202414:30GLOBEAlpha Tau to Participate in Barclays 26th Annual Global..
20/12/202315:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202315:15GLOBEAlpha Tau to Present at the 42nd Annual J.P. Morgan..
18/12/202317:09EDGAR2Form 144 - Report of proposed sale of securities
29/11/202314:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202314:30GLOBEAlpha Tau to Participate in Sidoti Small-Cap Conference
28/11/202314:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:30GLOBEAlpha Tau Announces Highly Promising Interim Results from..
21/11/202312:18EDGAR2Form 144 - Report of proposed sale of securities
20/11/202314:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202314:30GLOBEAlpha Tau Submits to Japanese PMDA for Pre-Market Approval..
16/11/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202322:30GLOBEAlpha Tau Medical Announces Third Quarter 2023 Financial..
01/11/202322:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202313:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202313:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202313:30GLOBEAlpha Tau Enters Into Long-Term Lease of Site in New..
24/10/202315:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202315:00GLOBEFormer U.S. Commissioner of Food and Drug Administration..
27/9/202313:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14/9/202314:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202314:30GLOBEAlpha Tau Treats First Patient with Advanced Inoperable..
11/9/202322:16EDGAR2Form F-3 - Registration statement by foreign private issuers
28/8/202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202322:02GLOBEAlpha Tau Medical Announces Second Quarter 2023 Financial..
24/8/202314:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202323:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/8/202323:00GLOBEAlpha Tau Announces Robust Long-Term Safety and Efficacy..
02/8/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202322:01GLOBEAlpha Tau Medical to Participate in June Investor..
23/5/202322:01GLOBEAlpha Tau Medical Announces First Quarter 2023 Financial..
17/5/202322:30GLOBEAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer..
11/5/202322:00GLOBEAlpha Tau Announces the Publication of its US Multicenter..
03/5/202322:00GLOBEAlpha Tau Medical to Present at Guggenheim..
Apertura: 2,45 Min: 2,1501 Max: 2,535
Chiusura: 2,40

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network